Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age

Philippe Grandjean1,2, Carsten Heilmann3, Pal Weihe4

  • 1a Department of Environmental Health , Harvard T.H. Chan School of Public Health , Boston , MA , USA.

Insights

Early life exposure to Per- and Polyfluoroalkyl Substances (PFAS) significantly reduces vaccine antibody responses in children. Breastfeeding amplifies these PFAS exposures, particularly in the first six months, impacting infant immune system development.

Area of Science:

  • Environmental Health
  • Immunotoxicology
  • Pediatric Health

Background:

  • Per- and Polyfluoroalkyl Substances (PFAS) are persistent environmental contaminants with potential immunotoxic effects.
  • Infant exposure to PFAS, including through breastfeeding, may attenuate antibody responses to childhood vaccines.
  • The developing immune system's vulnerability to environmental toxins during early life is a growing concern.

Purpose of the Study:

  • To investigate the association between prenatal and early infancy exposure to PFAS and antibody concentrations against tetanus and diphtheria vaccines at age 5.
  • To determine critical windows of vulnerability for PFAS-induced immunotoxicity during infancy.
  • To assess the impact of breastfeeding on PFAS exposure profiles and subsequent vaccine responses.

Main Methods:

  • A prospective birth cohort study in the Faroe Islands with clinical examinations and blood sample collection at 18 months and 5 years.
  • Measurement of PFAS concentrations at birth and during follow-up; estimation of infant serum PFAS profiles using breastfeeding data.
  • Analysis of serum antibody concentrations against tetanus and diphtheria vaccines at age 5, with pooled analysis including a previous cohort.

Main Results:

  • Prenatal PFAS exposure was inversely associated with antibody concentrations at age 5 (up to 20% decrease per doubling).
  • Estimated PFAS concentrations at 3 and 6 months of infancy showed the strongest inverse associations with antibody levels at age 5, especially for tetanus.
  • Joint analyses revealed significant decreases (19-29%) in tetanus antibody concentrations at age 5 per doubling of early infancy PFAS exposure.

Conclusions:

  • The developing adaptive immune system is particularly susceptible to PFAS immunotoxicity during infancy.
  • The first six months of life represent a critical window of vulnerability, influenced by breastfeeding-related PFAS exposures.
  • These findings highlight the need to minimize early life exposure to PFAS to protect vaccine efficacy and long-term immune health.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Vaccinations01:51

Vaccinations

Overview
52.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.3K